Dallas Diabetes & Endocrine Center is a clinical research site located in Dallas, Texas, United States 75230.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Dallas Diabetes & Endocrine Center has participated in 20 clinical trials.
Therapeutic areas: Diabetic Polyneuropathy, Type 2 Diabetes Mellitus, Diabetes Type 2.
Sponsors: MEDA Pharma GmbH & Co. KG, AstraZeneca, Mannkind Corporation.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dallas Diabetes & Endocrine Center has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dallas Diabetes & Endocrine Center has 20 clinical trials on record. Their work covers Diabetic Polyneuropathy, Type 2 Diabetes Mellitus, Diabetes Type 2.
Yes — Dallas Diabetes & Endocrine Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.